Best thing about here, you can focus on facts (not
Post# of 15624
(Total Views: 535)
Posted On: 03/05/2017 10:36:29 AM
Best thing about here, you can focus on facts (not bashers BS)
From the Street-Feb 17, (some nice insight in there)
OWC Pharmaceutical Research Corp. (OTCQB: OWCP), ("OWC" or the "Company"
, a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced that it will be presenting at the Wall Street Conference. The event will be held at the Hilton Doubletree Hotel and Conference Center in Deerfield Beach/ Boca Raton, Florida, on Wednesday, March 1, 2017
The Wall Street Conference is the premiere conference in the venture capital arena and small-cap marketplace. Conference participants include industry leaders from the hedge fund, investment banking, and private equity worlds, as well as sophisticated investors, who attend to discuss significant trends in the financial markets.
Ziv Turner, OWCP's VP Business development and Managing Director of One World Cannabis, the Company's wholly-owned subsidiary, will provide conference attendees with an update about the Company's progress, specifically focused on its research and products in development, and most importantly the Company's plans for the future, sales and marketing in the US, Canada and Europe this year (2017). The Company is currently scheduled to give its presentation on or around 3:30 PM, as a follow to its advisory board member, Mr. Jeffery Friedland's key tone session. Other management team members, Mr. Mordehai Bignitz, Chairman and CEO and Dr. Yehuda Baruch, Chief Science Officer will also be available for one-on-one discussions during the conference.
Mr. Turner commented on the Company's participation in the event, "The Wall Street Conference is one of the leading conferences for small-cap investors and OWC is excited to be a part of it. OWC continues to make significant progress in the research and development of cannabis-centric medical treatments, specifically with our psoriasis cream, which is being readied for the U.S. and European markets. We are focused on having our products on the shelves in the MMJ states this year. I am very much looking forward to discussing the Company with conference attendees."
From the Street-Feb 17, (some nice insight in there)
OWC Pharmaceutical Research Corp. (OTCQB: OWCP), ("OWC" or the "Company"
, a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced that it will be presenting at the Wall Street Conference. The event will be held at the Hilton Doubletree Hotel and Conference Center in Deerfield Beach/ Boca Raton, Florida, on Wednesday, March 1, 2017 The Wall Street Conference is the premiere conference in the venture capital arena and small-cap marketplace. Conference participants include industry leaders from the hedge fund, investment banking, and private equity worlds, as well as sophisticated investors, who attend to discuss significant trends in the financial markets.
Ziv Turner, OWCP's VP Business development and Managing Director of One World Cannabis, the Company's wholly-owned subsidiary, will provide conference attendees with an update about the Company's progress, specifically focused on its research and products in development, and most importantly the Company's plans for the future, sales and marketing in the US, Canada and Europe this year (2017). The Company is currently scheduled to give its presentation on or around 3:30 PM, as a follow to its advisory board member, Mr. Jeffery Friedland's key tone session. Other management team members, Mr. Mordehai Bignitz, Chairman and CEO and Dr. Yehuda Baruch, Chief Science Officer will also be available for one-on-one discussions during the conference.
Mr. Turner commented on the Company's participation in the event, "The Wall Street Conference is one of the leading conferences for small-cap investors and OWC is excited to be a part of it. OWC continues to make significant progress in the research and development of cannabis-centric medical treatments, specifically with our psoriasis cream, which is being readied for the U.S. and European markets. We are focused on having our products on the shelves in the MMJ states this year. I am very much looking forward to discussing the Company with conference attendees."
(1)
(0)